TGF-beta targeting nanoparticle formulation (Pfizer)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTGF-beta targeting nanoparticle formulation (Pfizer)
Drug Alias NameTGF-beta targeting nanoparticle formulation (BIND Therapeutics)TGF-beta targeting nanoparticle formulation (DNIB Unwind)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 modulators
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsImmune System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDNIB Unwind Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDNIB Unwind IncPfizer Inc
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A